Literature DB >> 4355135

Renin in hypertension: how important as a risk factor?

J Genest, R Boucher, O Kuchel, W Nowaczynski.   

Abstract

An analysis of the plasma renin levels in relation to the incidence of severe cardiovascular complications (coronary thrombosis, stroke, ruptured aortic aneurysm) was made in 325 patients with various types of hypertension. These patients had one to four measurements of plasma renin activity taken under standard conditions of sodium intake and posture in the period 1963-68. The follow-up was 5 to 10 years in the four groups of hypertensive patients (essential hypertension, malignant hypertension, hypertension secondary to renal parenchymatous disease and hypertension caused by, or associated with, renal artery obstruction). For all 325 patients, the incidence of such complications was 23.6, 20.4 and 44.7% in the low, normal and high renin groups. These findings are at variance with the claim that renin constitutes a serious risk factor in hypertensive patients, especially if it is isolated from other parameters such as the level of diastolic pressure, the adequacy of kidney function, the effectiveness of dietary and drug management of hypertension, and especially the presence or absence of atherosclerotic lesions of the large vessels at the time of the renin determination.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4355135      PMCID: PMC1946898     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS.

Authors:  R BOUCHER; R VEYRAT; J DE CHAMPLAIN; J GENEST
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

2.  Renal and adrenal factors in hypertension: diagnostic approaches.

Authors:  J H Laragh
Journal:  Bull N Y Acad Med       Date:  1969-09

3.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

4.  Prognosis in low renin hypertension.

Authors:  A Amery; R Stroobandt; R Fagard
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

  4 in total
  7 in total

1.  Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects.

Authors:  J Genest; R Boucher; O Kuchel; J M Rojo-Ortega; W Nowaczynski
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

2.  A practical approach to hypertension.

Authors:  A Dodek; G Wilkins
Journal:  Can Fam Physician       Date:  1976-12       Impact factor: 3.275

3.  Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.

Authors:  F Giacomelli; P Anversa; J Wiener
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

4.  Letter: Renin in hypertension.

Authors: 
Journal:  Can Med Assoc J       Date:  1974-01-05       Impact factor: 8.262

5.  Vesicle-associated membrane protein-2 (VAMP2) mediates cAMP-stimulated renin release in mouse juxtaglomerular cells.

Authors:  Mariela Mendez; Kenneth W Gross; Sean T Glenn; Jeffrey L Garvin; Oscar A Carretero
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

Review 6.  Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies.

Authors:  Girish Pathangey; Priyal P Fadadu; Alexandra R Hospodar; Amr E Abbas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-11-25       Impact factor: 5.464

Review 7.  Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.

Authors:  Rodrigo Pacheco Silva-Aguiar; Diogo Barros Peruchetti; Patricia Rieken Macedo Rocco; Alvin H Schmaier; Patrícia Machado Rodrigues E Silva; Marco Aurélio Martins; Vinícius Frias Carvalho; Ana Acacia Sá Pinheiro; Celso Caruso-Neves
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-12       Impact factor: 5.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.